NYSE:A - Agilent Technologies Stock Price, News, & Analysis

Agilent Technologies trades on the New York Stock Exchange (NYSE) under the ticker symbol "A."

Agilent Technologies announced a quarterly dividend on Wednesday, November 14th. Investors of record on Monday, December 31st will be given a dividend of $0.164 per share on Wednesday, January 23rd. This represents a $0.66 annualized dividend and a yield of 0.84%. The ex-dividend date of this dividend is Friday, December 28th. This is a boost from Agilent Technologies's previous quarterly dividend of $0.15. View Agilent Technologies' Dividend History.

Agilent Technologies declared that its Board of Directors has approved a stock buyback plan on Monday, November 19th 2018, which authorizes the company to repurchase $1,750,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization authorizes the company to reacquire up to 8.8% of its shares through open market purchases. Shares repurchase plans are usually an indication that the company's management believes its stock is undervalued.

Agilent Technologies Inc (NYSE:A) issued its earnings results on Monday, November, 19th. The medical research company reported $0.81 EPS for the quarter, beating analysts' consensus estimates of $0.74 by $0.07. The medical research company earned $1.29 billion during the quarter, compared to the consensus estimate of $1.26 billion. Agilent Technologies had a return on equity of 19.84% and a net margin of 6.43%. Agilent Technologies's quarterly revenue was up 8.8% on a year-over-year basis. During the same period in the previous year, the company earned $0.67 EPS. View Agilent Technologies' Earnings History.

Agilent Technologies is scheduled to release their next quarterly earnings announcement on Wednesday, February 20th 2019. View Earnings Estimates for Agilent Technologies.

Agilent Technologies will be holding an earnings conference call on Wednesday, February 20th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link.

7 Wall Street analysts have issued 12 month price objectives for Agilent Technologies' stock. Their forecasts range from $77.00 to $89.00. On average, they anticipate Agilent Technologies' stock price to reach $83.25 in the next year. This suggests a possible upside of 6.3% from the stock's current price. View Analyst Price Targets for Agilent Technologies.

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Agilent Technologies in the last year. There are currently 2 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Agilent Technologies.

Press coverage about A stock has trended somewhat positive on Tuesday, InfoTrie Sentiment reports. InfoTrie rates the sentiment of press coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Agilent Technologies earned a news impact score of 1.4 on InfoTrie's scale. They also gave media coverage about the medical research company a news buzz of 6.0 out of 10, indicating that recent press coverage is somewhat likely to have an impact on the stock's share price in the near term.

Some companies that are related to Agilent Technologies include Illumina (ILMN), Waters (WAT), Mettler-Toledo International (MTD), PerkinElmer (PKI), Bio-Rad Laboratories (BIO), Bio-Rad Laboratories (BIO.B), Bruker (BRKR), Coherent (COHR), Horiba (HRIBF), Accelerate Diagnostics (AXDX), Pacific Biosciences of California (PACB), Quanterix (QTRX), Fluidigm (FLDM), Eyepoint Pharmaceuticals (EYPT) and Harvard Bioscience (HBIO).

Agilent Technologies' stock is owned by many different of institutional and retail investors. Top institutional investors include BlackRock Inc. (7.84%), Geode Capital Management LLC (1.33%), Northern Trust Corp (1.20%), Findlay Park Partners LLP (1.15%), Cantillon Capital Management LLC (1.12%) and D. E. Shaw & Co. Inc. (1.10%). Company insiders that own Agilent Technologies stock include Boon Hwee Koh, Didier Hirsch, Dominique Grau, Heidi Fields, Jacob Thaysen, James Cullen, Mark Doak, Michael R Mcmullen, Patrick G Hagan, Patrick Kaltenbach, Paul N Clark and Rodney Gonsalves. View Institutional Ownership Trends for Agilent Technologies.

A stock was sold by a variety of institutional investors in the last quarter, including D. E. Shaw & Co. Inc., BlackRock Inc., Millennium Management LLC, MERIAN GLOBAL INVESTORS UK Ltd, Canada Pension Plan Investment Board, State of Tennessee Treasury Department, Orbimed Advisors LLC and Bank of New York Mellon Corp. Company insiders that have sold Agilent Technologies company stock in the last year include Boon Hwee Koh, Dominique Grau, Heidi Fields, Michael R Mcmullen, Patrick Kaltenbach, Paul N Clark and Rodney Gonsalves. View Insider Buying and Selling for Agilent Technologies.

A stock was bought by a variety of institutional investors in the last quarter, including Findlay Park Partners LLP, Oregon Public Employees Retirement Fund, Pendal Group Ltd, Two Sigma Advisers LP, Geode Capital Management LLC, Bank of Nova Scotia, Mackay Shields LLC and Thrivent Financial for Lutherans. View Insider Buying and Selling for Agilent Technologies.

Shares of A can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of A stock can currently be purchased for approximately $78.30.

Agilent Technologies has a market capitalization of $24.87 billion and generates $4.91 billion in revenue each year. The medical research company earns $316 million in net income (profit) each year or $2.79 on an earnings per share basis. Agilent Technologies employs 14,800 workers across the globe.

The official website for Agilent Technologies is http://www.agilent.com.

Agilent Technologies' mailing address is 5301 STEVENS CREEK BLVD, SANTA CLARA CA, 95051. The medical research company can be reached via phone at 408-345-8886 or via email at [email protected]